Catheter Precision closes $3.47M Series C-2 preferred; issues $11M Series D for Flyte acquisition

Catheter Precision, Inc.

3,470 shares of Series C-2 Preferred at $1,000 stated value sold for gross proceeds of $3,470,000.
11,028 shares of Series D Preferred ($11.03M stated value) issued to SEG Jets and Creatd for Fly Flyte acquisition.
Series C-2 conversion price $0.883/share, floor $0.35; Series D conversion price $1.1038/share, subject to reduction.
Stockholder approval obtained April 15, 2026; proceeds for working capital and general corporate purposes.
Beneficial ownership limitation initially 4.99%, can be increased to 9.99% on 61 days' notice.

item 3.02item 3.03item 5.03item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.